Nymox Pharmaceutical (NYMXF) Receivables - Other (2015 - 2024)
Nymox Pharmaceutical's Receivables - Other was $27,000 in Q4 2024, up 145.5% from $11,000 a year earlier and up 17.4% from the prior quarter.
Analysis
Nymox Pharmaceutical (NYMXF) Receivables - Other (2015 - 2024) Analysis & Trends
From Q4 2015 onward, Nymox Pharmaceutical has reported Receivables - Other for 29 quarters.
- Receivables - Other shows a five-year compound annual growth rate of 14.0% (FY2019 to FY2024).
- In earlier years, Receivables - Other was $11,000 in FY2023 (+10.0%), $10,000 in FY2022 (-23.1%), $13,000 in FY2021 (-35.0%) and $20,000 in FY2020 (+42.9%).
- The Q4 2024 figure marks the highest quarterly Receivables - Other in data going back to Q4 2015.
- Compared with a year earlier, Receivables - Other was higher in four of the last six quarters, with growth averaging 60.9%.
- The best year-over-year quarter for Receivables - Other over five years was Q3 2024 (growth of 228.6%); the worst was Q2 2022 (a decline of 35.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Nymox Pharmaceutical | 6.12 Mn | 5.93 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 10,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 14,000.00 |
| Mar 31, 2021 | 15,000.00 |
| Dec 31, 2020 | 20,000.00 |
| Sep 30, 2020 | 18,000.00 |
| Jun 30, 2020 | 15,000.00 |
| Mar 31, 2020 | 12,000.00 |
| Dec 31, 2019 | 14,000.00 |
| Sep 30, 2019 | 13,000.00 |
API Access
Nymox Pharmaceutical Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=NYMXF&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();